Ask AI
ProCE Banner Activity

Charting a New Course in Severe Hypertriglyceridemia Care: Optimizing Diagnosis, Therapeutic Strategies, and Pancreatitis Prevention in sHTG and FCS

Slideset

Explore best practices for improving diagnosis and management of severe hypertriglyceridemia (sHTG) and familial chylomicronemia syndrome (FCS) by focusing on reducing triglyceride levels and preventing acute pancreatitis in patients with sHTG or FCS.

Released: June 02, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Target Audience

This activity is intended for endocrinology physicians, nurse practitioners, and physician associates and other healthcare professionals involved in the care of patients with sHTG, including FCS.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify the pathophysiology and clinical indicators of severe hypertriglyceridemia and FCS to support timely and accurate diagnosis 

  • Evaluate current and emerging treatment strategies for severe hypertriglyceridemia and FCS to guide individualized patient management 

  • Incorporate evidence-based management strategies that address disease burden, unmet treatment needs, and pancreatitis risk in patients with severe hypertriglyceridemia, including FCS